Researchers found a natural mutation of the SUMO-4 gene, which regulates immune system activity, to be a major contributor to type 1 diabetes. The mutation increases the immune system's reactivity to environmental triggers, leading to an autoimmune response that attacks the patient's own tissue.
FUZEON shows significant benefits in health improvements and reduced side effects for HIV patients, yet many are missing out due to fear of injection. Physicians and nurses play a pivotal role in educating patients on optimal use of FUZEON.
A six-month study found that providing primary care to nearly 2,000 HIV-infected patients costs an average of $30 USD per visit. The breakdown includes staff salaries, laboratory tests, and medications.
The Guava EasyCD4 and EasyCD8 assays provide comparable accuracy to flow cytometry methods but are simpler and more affordable, enabling global access to affordable HIV/AIDS patient monitoring. These lower-cost alternatives can significantly improve quality of care and life for millions of HIV+ patients in resource-limited countries.